1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)

Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites research to understand and mitigate health disparities in the development, diagnosis, and treatment of diseases of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research is encouraged in the following high priority diseases: diabetes and other endocrine and metabolic diseases; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; metabolic, gastrointestinal, hepatic, and renal complications from infection with HIV; and mechanistic research in hematologic diseases, including studies in abnormal hemoglobin synthesis.
This FOA will not support multi-center clinical studies or Clinical Trials. Animal research is allowed if the research is a clinically relevant model of a NIDDK mission area disease in a minority population.

Funding Opportunity Details

PA-18-412
None

Salina P. Waddy, MD; Frank A. Hamilton, MD; Pamela Thornton, PhD; Andrew Narva, M.D.

Key Dates

1/5/2018

Not Applicable

Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.